NanoDel Technologies Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Latest Deal Type
-
Merger of Eq.
NanoDel Technologies General Information
Description
Researcher and developer of drug carrier systems. The company develops nanoparticle based technology to deliver compounds that are suitable for the treatment of brain tumors and other acute and chronic CNS related disorders, such as brain infections, neuroprotection, epilepsy, Alzheimer's disease and others.
Contact Information
Primary Industry
Drug Delivery
Acquirer
Capsulution Pharma
Primary Office
- Leipziger Straße 44 (ZENIT)
- 39120 Magdeburg
- Germany
NanoDel Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger of Equals | 17-Nov-2008 | 00.000 | Completed | Generating Revenue | ||
| 3. Angel (individual) | 01-Dec-2006 | 00.000 | 00.000 | Completed | Startup | |
| 2. Angel (individual) | 01-Jun-2005 | $1.2M | Completed | Startup | ||
| 1. Seed Round | 01-Jun-2004 | $1.2M | $1.2M | Completed | Startup |
NanoDel Technologies Patents
NanoDel Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20090297613-A1 | Nanoparticles designed for drug delivery | Inactive | 03-Feb-2006 | 0000000000 | |
| CA-2640557-A1 | Nanoparticles designed for drug delivery | Inactive | 03-Feb-2006 | 0000000000 | |
| EP-1978946-A2 | Nanoparticles designed for drug delivery | Inactive | 03-Feb-2006 | 0000000000 | |
| EP-1815851-A1 | Nanoparticles designed for drug delivery | Inactive | 03-Feb-2006 | 0000000000 | 0 |
| EP-1661559-A1 | Delivery vehicle manufactured by the miniemulsion method | Inactive | 25-Nov-2004 | A61K9/5138 | 0 |
NanoDel Technologies Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Karim Balan Ph.D | Interim Chief Executive Officer & Co-Founder | ||
| Joachim Bender Ph.D | Chief Executive Officer |